After six years of use and critique, the European Union Clinical Trials Directive is scheduled for overhaul in 2011. Commissions, Conferences and consortia have met, discussed, evaluated and conferred.
In this paper Pharma IQ begins by taking a brief look at the development of the Clinical Trial Directive, then distils the substance and flavour of the debate currently taking place in scientific circles throughout the European Union and beyond. Our review summarises the major issues and possible remedies, then looks to the future as industry experts share their thoughts about what should happen in terms of reform and what is most likely to happen in 2011.
Download Brochure
Please complete the information below to complete your download.
Please note: That all fields marked with an asterisk (*) are required.
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
|
|
What are the 7 Deadly Sins of Quality Assurance and Quality Control?
Download our free QA QC eBook now to find out!